| Net Income Per Share |
Net Income Per Share A reconciliation of net income available to common stockholders and the number of shares in the calculation of basic and diluted earnings income per share was calculated as follows: | | | | | | | | | | | | | | | | | | | | | | | | | For the Three Months Ended June 30, | | For the Six Months Ended June 30, | | (Dollars in thousands, except for share and per share amounts) | 2026 | | 2025 | | 2026 | | 2025 | | Net income attributable to Privia Health Group, Inc. common stockholders | $ | 9,048 | | | $ | 2,687 | | | $ | 12,112 | | | $ | 6,907 | | | Weighted average common shares outstanding - basic | 126,121,426 | | | 122,132,245 | | | 125,142,415 | | | 121,370,949 | | | Weighted average common share outstanding - diluted | 131,827,233 | | | 128,447,069 | | | 131,355,421 | | | 128,149,252 | | | Earnings per share attributable to Privia Health Group, Inc. common stockholders – basic | $ | 0.07 | | | $ | 0.02 | | | $ | 0.10 | | | $ | 0.06 | | | Earnings per share attributable to Privia Health Group, Inc. common stockholders – diluted | $ | 0.07 | | | $ | 0.02 | | | $ | 0.09 | | | $ | 0.05 | |
Below are the weighted-average diluted shares outstanding that were excluded from the computation of diluted loss per share attributable to common stockholders for the period presented because they were anti-dilutive: | | | | | | | | | | | | | Six Months Ended June 30, | | 2026 | | 2025 | | Weighted-average antidilutive shares outstanding | 4,116,262 | | | 4,931,666 | |
|